Correlation Analysis Between Single Nucleotide Polymorphism of ITS Sequences and Profile of Steroidal Saponins Composition of Paris polyphylla var.yunnanensis
Author:
Fund Project:

National Sciences Foundation of China (Grant No. 81573545); Technology Innovation and Research and Development Project of Chengdu Science and Technology Bureau (Grant No. 2019-YF05-00346-SN); Apricot Grove Scholars Program of Chengdu University of TCM(Grant No. QNXZ2018039)

  • Article
  • | |
  • Metrics
  • |
  • Reference [21]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    In order to understand the correlation between characters of single nucleotide polymorphism (SNP) of internal transcribed spacer (ITS) sequences and composition of steroidal saponins of Paris polyphylla var. yunnanensis, the effect of SNP on the quality stability of medicinal materials, the ITS sequences of 37 samples were compared by MegAlign, and then classified according to SNP loci. In addition, 7 steroidal saponins (polyphyllin Ⅰ, Ⅱ, Ⅴ, Ⅵ, Ⅶ, H, dioscin) in samples were determined by HPLC-DAD. The steroidal saponin composition characteristics of each genotype were statistical analysis by SPSS 25.0 & SIMCA-P 15.0. The results showed that there were 40 double-allelic polymorphic sites in ITS sequences of P. polyphylla var. yunnanensis, including 32 base conversion sites and 8 base inversion sites. According to SNP characteristics, 37 samples were divided into two genotypes: YN-I and YN-II. Six kinds of steroidal saponins (polyphyllin Ⅰ, Ⅱ, Ⅵ, Ⅶ, H, dioscin) were widely distributed in samples, while polyphyllin Ⅴ was relatively rare. The mean total content of pharmacopoeia index components in YN-I and YN-II were 1.070% and 0.93%, which the sample pass rate were 68.42% and 77.78%, respectively. The mean total content of 7 steroidal saponins were 1.65% and 1.32%, respectively. ANOVA analysis showed that there was significant differentiation of steroidal saponins profile between two genotypes, while there was no significant difference in the index components of pharmacopoeia, so the medicinal value of two genotypes should be equivalent. Cluster analysis (CA) and principal component analysis (PCA) showed the dispersion of YN-I was higher than that of YN-II, indicating the quality of medicinal materials of YN-II was more stable and the individual differences in steroidal saponins synthesis and accumulation in YN-II was smaller than YN-I. Therefore, the SNP characteristics of YN-II were of great significance for the screen of molecular genetic markers in the breeding of Paris polyphylla var. yunnanensis.

    Reference
    [1] Chinese Pharmacopoeia Commission. Pharmacopoeia of People's Republic of China[M]. Beijing:China Medical Science Press, 2020:271-272.国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社, 2020:271-272.
    [2] LI H, SU B, ZHANG Z Y, et al. An assessment on the rarely medical Paris plants in China with exploring the future development of its plantation[J]. J W China For Sci, 2015, 44(3):1-7. doi:10.16473/j. cnki.xblykx1972.2015.03.001.李恒,苏豹,张兆云,等.中国重楼资源现状评价及其种植业的发展对策[J].西部林业科学, 2015, 44(3):1-7. doi:10.16473/j.cnki.xb lykx1972.2015.03.001.
    [3] LIU Q, FAN X L, YANG L, et al. Screening and evaluation of three excellent Paris resources from mountain area of Sichuan Basin[J]. Chin Trad Herb Drugs, 2019, 50(2):526-534. doi:10.7501/j.issn.0253-2670.2019.02.035.刘琴,樊小莉,杨莉,等.四川盆周山地重楼属植物药用资源的筛选及评价[J].中草药, 2019, 50(2):526-534. doi:10.7501/j.issn.0253-2670.2019.02.035.
    [4] ZHANG K Y, RAO W X, YIN X M, et al. Multiplex PCR system for the identification of paridis rhizoma's legal origins and its closely related species from genus Paris[J]. Nat Prod Res Dev, 2018, 30(12):2193-2202. doi:10.16333/j.1001-6880.2018.12.025.张开元,饶文霞,尹显梅,等.重楼法定基原与其同属近缘种的多重PCR鉴别体系研究[J].天然产物研究与开发, 2018, 30(12):2193-2202. doi:10.16333/j.1001-6880.2018.12.025.
    [5] LI P, XUE D, WEN F Y, et al. Description and supplement of morphology and the characteristics of saponin components of Paris forrestii(Takht) H. Li[J]. Lishizhen Med Mat Med Res, 2016, 27(1):200-202. doi:10.3969/j.issn.1008-0805.2016.01.079.李朋,薛丹,文飞燕,等.长柱重楼形态描述补充及其皂苷类成分特征[J].时珍国医国药, 2016, 27(1):200-202. doi:10.3969/j.issn. 1008-0805.2016.01.079.
    [6] WEN F Y, YIN H X, CHEN C, et al. Chemical characteristics of saponins from Paris fargesii var. brevipetala and cytotoxic activity of its main ingredient, paris saponin H[J]. Fitoterapia, 2012, 83(4):627-635. doi:10.1016/j.fitote.2012.01.003.
    [7] LI L Y, LI S P, YANG B, et al. Morphological variations of Paris polyphylla var. yunnansensis in different population[J]. Chin J Chin Mat Med, 2010, 35(22):2959-2962. doi:10.4268/cjcmm20102205.李林玉,李绍平,杨斌,等.滇重楼不同居群形态变异研究[J].中国中药杂志, 2010, 35(22):2959-2962. doi:10.4268/cjcmm20102205.
    [8] ZHANG K Y. The fluorescent visual identification of two genotypes of Paris polyphylla var. yunnanensis and the study of their chemical characteristics correlation[D]. Chengdu:Chengdu University of TCM, 2018:11-32. 张开元.两种基因型云南重楼的荧光可视化真伪鉴定及化学特征相关性研究[D].成都:成都中医药大学, 2018:11-32.
    [9] CHEN Z S Z, TIAN B, CAI C T. Genetic diversity of Paris polyphylla var. yunnanensis by SSR marker[J]. Chin Trad Herb Drugs, 2017, 48(9):1834-1838. doi:10.7501/j.issn.0253-2670.2017.09.021.陈中苏直,田波,蔡传涛.基于SSR分子标记的滇重楼遗传多样性研究[J].中草药, 2017, 48(9):1834-1838. doi:10.7501/j.issn.0253-2670.2017.09.021.
    [10] LI G, WANG Y F, TANG L, et al. Phenotypic trait variation, principal component, correlation and path analysis of Paris polyphylla var. yunnanensis[J]. J Chin Med Mat, 2015, 38(7):1339-1342. doi:10. 13863/j.issn1001-4454.2015.07.001.李戈,王艳芳,唐玲,等.滇重楼表型性状变异、主成分、相关及通径分析[J].中药材, 2015, 38(7):1339-1342. doi:10.13863/j.issn 1001-4454.2015.07.001.
    [11] WANG Q, DING Y, YANG M, et al. Correlation analysis of quality, origin and phenotypic characters of Paris polyphylla var. yunnanensis[J]. Chin J Chin Mat Med, 2019, 44(15):3203-3212. doi:10.19540/j. cnki.cjcmm.20190527.102.王骞,丁媛,杨敏,等.滇重楼品质与产地和表型性状相关性分析[J].中国中药杂志, 2019, 44(15):3203-3212. doi:10.19540/j.cnki.cj cmm.20190527.102.
    [12] WU Y Y, JIN L, MA Y J, et al. A comparative study on the fingerprint of Paris polyphylla var. polyphylla and Paris polyphylla var. yunna-nensis from different origins in Dali and seven main steroidal saponins by HPLC[J]. Chin Pharm J, 2020, 55(11):875-882. doi:10.11669/cpj.2020.11.004.吴钰颖,金琳,马永军,等.大理不同产地多叶重楼与云南重楼HPLC指纹图谱及7种主要甾体皂苷成分的比较研究[J].中国药学杂志, 2020, 55(11):875-882. doi:10.11669/cpj.2020.11.004.
    [13] CHEN L, ZHANG J B. Biosynthesis of steroidal saponins[J]. Nat Prod Res Dev, 2007, 19(2):316-320. doi:10.3969/j.issn.1001-6880.2007. 02.037.陈莉,张剑波.甾体皂甙的生物合成[J].天然产物研究与开发, 2007, 19(2):316-320. doi:10.3969/j.issn.1001-6880.2007.02.037.
    [14] HUANG X X, GAO W Y, MAN S L, et al. Advances in studies on saponins in plants of Paris L. and their biosynthetic approach[J]. Chin Trad Herb Drugs, 2009, 40(3):483-489. doi:10.3321/j.issn:0253-2670. 2009.03.044.黄贤校,高文远,满淑丽,等.重楼属药用植物皂苷类化学成分及其生源途径的研究进展[J].中草药, 2009, 40(3):483-489. doi:10. 3321/j.issn:0253-2670.2009.03.044.
    [15] GAO F, LUO X P, TAO L, et al. Molecular cloning of squalene synthase gene form Paris polyphylla and its expression in Escherich coli[J]. Chin J Chin Mat Med, 2013, 38(13):2086-2091. doi:10.4268/cjcmm20131310.高飞,雒晓鹏,陶亮,等.滇重楼鲨烯合酶基因PpSQS的克隆及在大肠杆菌中的表达[J].中国中药杂志, 2013, 38(13):2086-2091. doi:10.4268/cjcmm20131310.
    [16] XU Y, ZHAO S, DONG X, et al. Cloning and expression of squalene epoxidase from Paris polyphylla var. yunnanensis[J]. Chin Trad Herb Drugs, 2017, 48(9):1839-1844. doi:10.7501/j.issn.0253-2670.2017. 09.022.许燕,赵爽,董栩,等.滇重楼鲨烯环氧酶基因的克隆及原核表达研究[J].中草药, 2017, 48(9):1839-1844. doi:10.7501/j.issn.0253-2670.2017.09.022.
    [17] YANG L, FAN X L, LIU Q, et al. Molecular cloning and analysis of pyrophospomevalonate decarboxylase gene from Paris polyphylla var. yunnanensis[J]. Chin Trad Herb Drugs, 2019, 50(6):1435-1441. doi:10.7501/j.issn.0253-2670.2019.06.027.杨莉,樊小莉,刘琴,等.滇重楼甲羟戊酸焦磷酸脱羧酶基因的分子克隆与分析[J].中草药, 2019, 50(6):1435-1441. doi:10.7501/j. issn.0253-2670.2019.06.027.
    [18] YUAN M Q, DING C B, TAO L, et al. Cloning and sequence analysis of cycloartenol synthase gene from Paris polyphylla var. yunnanensis[J]. Chin Trad Herb Drugs, 2012, 43(11):2250-2256.袁梦求,丁春邦,陶亮,等.滇重楼环阿屯醇合酶基因的克隆及序列分析[J].中草药, 2012, 43(11):2250-2256.
    [19] YIN Y, GAO L H, ZHANG X N, et al. A cytochrome P450 mono-oxygenase responsible for the C-22 hydroxylation step in the Paris polyphylla steroidal saponin biosynthesis pathway[J]. Phytochemistry, 2018, 156:116-123. doi:10.1016/j.phytochem.2018.09.005.
    [20] LI X J, YANG Z Y, HUANG Y L, et al. Complete chloroplast genome of the medicinal plant Paris polyphylla var. chinensis(Melanthiaceae)[J]. J Trop Subtrop Bot, 2015, 23(6):601-613. doi:10.11926/j.issn. 1005-3395.2015.06.001.李晓娟,杨振艳,黄玉玲,等.药用植物华重楼(黑药花科)叶绿体全基因组研究[J].热带亚热带植物学报, 2015, 23(6):601-613. doi:10.11926/j.issn.1005-3395.2015.06.001.
    [21] LI H T, LUO X W, GUAN Y H, et al. Comparison between content of saponins of Paris polyphylla var. yunnanensis in different areas of Yunnan Province[J]. Chin J Chin Mat Med, 2014, 39(5):803-806. doi:10.4268/cjcmm20140509.李海涛,罗先文,管燕红,等.云南省不同地区滇重楼皂苷含量的对比及影响因子分析[J].中国中药杂志, 2014, 39(5):803-806. doi:10.4268/cjcmm20140509.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

尹鸿翔,张开元,任梓萱,赵家雯,蒋桂华,陈蓉.云南重楼ITS序列单核苷酸多态性与甾体皂苷特征的相关性分析[J].热带亚热带植物学报,2022,30(5):676~686

Copy
Share
Article Metrics
  • Abstract:166
  • PDF: 348
  • HTML: 325
  • Cited by: 0
History
  • Received:August 05,2021
  • Revised:November 05,2021
  • Adopted:June 09,2022
  • Online: September 26,2022
Article QR Code